Koyfin Home > Directory > Health Care > Polarityte Inc

Polarityte Inc Price Chart PTE

Historical daily share price chart and data for Polarityte Inc since 2003 adjusted for splits and dividends. The latest closing price for Polarityte Inc as of December 04, 2020 is $0.686.
  • In 2020 the stock opened at $2.66 and closed at $0.69 for a loss of -288% YTD.
  • In 2019 the stock opened at $13.47 and closed at $2.60 for a loss of -418%.
  • In 2018 the stock opened at $23.69 and closed at $13.49 for a loss of -76%.
  • In 2017 the stock opened at $3.30 and closed at $23.21 for a gain of 86%.
View Chart On Koyfin

Polarityte Inc Summary

Stock Symbol: PTE

Polarityte Inc Company Info

PolarityTE, Inc., a biotechnology and regenerative biomaterials company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
277.85 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of PTE Prices